AusPAR: Sacituzumab govitecan

Australian Public Assessment Report

AusPAR

AusPAR: Sacituzumab govitecan [PDF, 710.68 KB]

AusPAR: Sacituzumab govitecan [Word, 598.35 KB]

Attachment: Product information for Sacituzumab govitecan [PDF, 412.99 KB]

Attachment: Product information for Sacituzumab govitecan [Word, 311.14 KB]

Device/Product Name

Trodelvy

Active ingredients

Sacituzumab govitecan

AusPAR Date

3 September 2021

Published

29 March 2022

Submission Number

PM-2021-00038-1-4

Submission Type

New biological entity

Decision

Approved